200 related articles for article (PubMed ID: 7386598)
1. Further observations on the effect of cyclophosphamide on intratumor and peripheral leukocyte levels.
Evans R
Am J Pathol; 1980 Jun; 99(3):667-84. PubMed ID: 7386598
[TBL] [Abstract][Full Text] [Related]
2. Intratumor gene expression after adoptive immunotherapy in a murine tumor model. Regulation of messenger RNA levels associated with the differential expansion of tumor-infiltrating lymphocytes.
Evans R; Kamdar SJ; Duffy T; Edison L
J Immunol; 1993 Jan; 150(1):177-84. PubMed ID: 8417123
[TBL] [Abstract][Full Text] [Related]
3. Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity.
Fisher B; Wolmark N
Cancer Res; 1976 Jul; 36(7 PT 1):2241-7. PubMed ID: 1277129
[TBL] [Abstract][Full Text] [Related]
4. Changes in tumor-associated NK 1.1+ large granular lymphocyte precursors after cyclophosphamide injection: in vitro characterization and potential therapeutic application.
Krupke DM; Fuller J; Aslakson C; Evans R
Nat Immun; 1994; 13(5):246-57. PubMed ID: 7833624
[TBL] [Abstract][Full Text] [Related]
5. Effect of low frequency low energy pulsing electromagnetic fields on mice injected with cyclophosphamide.
Cadossi R; Zucchini P; Emilia G; Franceschi C; Cossarizza A; Santantonio M; Mandolini G; Torelli G
Exp Hematol; 1991 Mar; 19(3):196-201. PubMed ID: 1995311
[TBL] [Abstract][Full Text] [Related]
6. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
[TBL] [Abstract][Full Text] [Related]
7. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
Yeager AM; Levin FC; Levin J
J Cell Physiol; 1982 Aug; 112(2):222-8. PubMed ID: 7119022
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow and peripheral blood modifications in C57BL mice administered with cyclophosphamide and levan.
Siegal A; Kopel S; Bar-Sela S; Davidai G; Yavetz H; Leibovici J
In Vivo; 1988; 2(5):349-59. PubMed ID: 2979857
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.
Awwad M; North RJ
Cancer Res; 1989 Apr; 49(7):1649-54. PubMed ID: 2522344
[TBL] [Abstract][Full Text] [Related]
10. The influence of cyclophosphamide on antibody formation in the mouse.
Willers JM; Sluis E
Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
[TBL] [Abstract][Full Text] [Related]
11. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
Russell PS; Chase CM; Burton RC
J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic rescue via T-cell-dependent, endogenous granulocyte-macrophage colony-stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice.
Maestroni GJ; Covacci V; Conti A
Cancer Res; 1994 May; 54(9):2429-32. PubMed ID: 8162592
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
14. [The effect of NGF on hematopoiesis of granulocyte-macrophage in normal and radiation, chemistry injury mice].
Huang XQ; Zhu BD; Jiang-Yang-ze-ren
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):757-62. PubMed ID: 19024307
[TBL] [Abstract][Full Text] [Related]
15. Effect of continuous administration of interleukin 2 on active specific chemoimmunotherapy with extracted tumor-specific transplantation antigen and cyclophosphamide.
Naito K; Pellis NR; Kahan BD
Cancer Res; 1988 Jan; 48(1):101-8. PubMed ID: 3257158
[TBL] [Abstract][Full Text] [Related]
16. Role of interleukin 1 and granulocyte colony-stimulating factor in photofrin-based photodynamic therapy of rat rhabdomyosarcoma tumors.
de Vree WJ; Essers MC; Koster JF; Sluiter W
Cancer Res; 1997 Jul; 57(13):2555-8. PubMed ID: 9205052
[TBL] [Abstract][Full Text] [Related]
17. Cooperation between cyclophosphamide tumoricidal activity and host antitumor immunity in the cure of mice bearing large MOPC-315 tumors.
Hengst JC; Mokyr MB; Dray S
Cancer Res; 1981 Jun; 41(6):2163-7. PubMed ID: 7016310
[TBL] [Abstract][Full Text] [Related]
18. IL-15 mediates anti-tumor effects after cyclophosphamide injection of tumor-bearing mice and enhances adoptive immunotherapy: the potential role of NK cell subpopulations.
Evans R; Fuller JA; Christianson G; Krupke DM; Troutt AB
Cell Immunol; 1997 Jul; 179(1):66-73. PubMed ID: 9259773
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
[TBL] [Abstract][Full Text] [Related]
20. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance.
Milas L; McBride WH; Hunter N; Ito H
Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
